United States:
FDA Extends Nomination Period For List Of Bulk Drugs Used By Outsourcing Facilities
To print this article, all you need is to be registered or login on Mondaq.com.
In the July 20, 2015, Federal Register, FDA announced
it was extending the nomination period for bulk drug substances
that may be used by facilities registered as outsourcing facilities
to compound animal drugs from bulk substances. Nominations are due
November 16, 2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
